Pharma-Safe tar i bruk epidemiologiske metoder for å forske på problemstillinger som ikke kan studeres i randomiserte kontrollerte, studier slik som sikkerhet av legemidler i svangerskapet. Forskninger omfatter også pasienter holdninger, legemiddelrelaterte problemer, helseøkonomi og farmasøytens rolle i helsevesenet. Forskningsgruppen er tverrfaglig og har ekspertise innen farmakoepidemiologi, farmakoterapi, medisinsk statistikk, helseøkonomi, kvalitative forskningsmetoder og utviklingspsykologi. Les mer om Pharma-Safe på de engelske sidene.
Gruppemedlemmer på Farmasøytisk institutt
- Professor Hedvig Nordeng
- Associate Professor Ingunn Björnsdottir
- Professor II Erik Nord (health economics)
- Senior Researcher Eivind Ystrøm
- Senior Researcher Robert Lyle
- Post doc Angela Lupattelli
- Post doc Kristine Heitmann
- Post doc Mollie Wood
- PhD student Gerd Marie Eskerud Harris
- PhD student Johanne Naper Trønnes
- PhD student Bich Thuy Truong
- PhD student Seid Mussa
- PhD student Anna-Simone Josefine Frank
- PhD student Lene Maria Sundbakk
- Universitetslektor Hilde Louise Ariansen
Gjesteforskere 2017
- Senior advisor Gro C Havnen, Regional Drug Information Services Sør-Øst
Gjesteforskere 2016
- Dr. Jacqueline Cohen, Harvard T.H. Chan School of Public Health, Boston, USA
Gjesteforskere 2015
- Dr. Herbert Juch, Research Unit Human Teratogens, TIS Graz, Austria
- Dr. Michael Twigg, School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK
- Richelle Vlenterie, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherland
Nasjonale gruppemedlemmer
- Professor Olav Spigset, St Olav’s hospital, Trondheim
- Associate professor Lone Holst, University of Bergen (UiB)
- Senior scientist dr. med. Malin Eberhard-Gran, National Institute of Public Health (FHI)
- Senior advisor Gro C Havnen, Regional Drug Information Services Sør-Øst
- Advisor Helle Lindland-Tjønn, Regional Drug Information Services Sør-Øst
- PhD student Siri Amundsen, Universitetssykehuset Nord Norge (UNN)
- PhD student Elin Høien Bergene, Norwegian University of Science and Technology (NTNU)
Samarbeid
PharmaSafe gruppen arbeider sammen med:
- Center for Pharmacy, University of Bergen
- University hospitals in Norway (Rikshospitalet, OUS, UNN, St. Olav’s hospital, Akershus)
- Division for Mental Health, National Institute of Public Health, Norway
- Regional Drug Information Services
- University of Reykjavik, Iceland
- University of Copenhagen, Denmark
- Motherisk program, Hospital for Sick Children/University of Toronto, Canada.
The following are collaborators in the multinational Medication in Pregnancy project:
- Debra Kennedy MD, MotherSafe, Royal Hospital for Women and University of NSW, Randwick, Australia
- Katri Hameen-Anttila PhD, Finnish Medicines Agency, Helsinki, Finland
- Ann-Charlotte Mårdby, Department of Public Health and Community Medicine, Göteborg University, Sweden
- Ksenia Zagorodnikova MD PhD, Northwest Medical Center for Drug Safety in Pregnancy, St. Petersburg, Russia
- Marina Petrić PhD research fellow, Faculty of pharmacy, University of Belgrade, Serbia
- Gorazd Rudolf MD, Division of Medical Genetics, University Medical Centre Ljubljana, Slovenia
- Herbert Juch MD, Research Unit Human Teratogens, TIS Graz, Austria
- Alice Panchaud MD, Division de Pharmacologie Cliniques, Centre Hospitalier Universitaire Vaudois, Switzerland
- Mariola Drozd, PhD in pharmacy, Faculty of Pharmacy, Medical University of Lublin, Poland
- Michael Twigg, Research Pharmacist, School of Pharmacy, University of East Anglia, United Kingdom
